compounded semaglutide ban update Did the FDA and Tirzepatide? How compounders plan to continue

The inflammation following exercise serves anabolic signaling functions, and suppressing it too aggressively may reduce training gains

It is so good to be back on the blog today

What remains most novel about GLP-1 medications is that they target underlying biological drivers of energy intake and metabolic regulationfactors closely tied to chronic disease riskrather than simply promoting short-term weight reduction, and may, in the long run, contribute to lower health insurance costs by treating related comorbidities, even as they may impact patient longevity and, thus, how life insurance treats these drugs

Brian B